Radiopaque Matrix MK-8591 Implant in Participants at Low-Risk for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591-043)
Clinical trial NCT05115838 · WITHDRAWN
Trial details
- NCT number
- NCT05115838
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-04
- Primary completion
- 2025-10-02
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.